Kymera Therapeutics
KYMR
#3839
Rank
NZ$4.54 B
Marketcap
$70.22
Share price
-2.13%
Change (1 day)
32.06%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2023 (TTM): -$4.67

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.09. In 2022 the company made an earnings per share (EPS) of -$5.11 a decrease over its 2021 EPS that were of -$3.65.

EPS history for Kymera Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.67-8.64%
2022-$5.1139.81%
2021-$3.6522.84%
2020-$2.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.87-24.04%๐Ÿ‡บ๐Ÿ‡ธ USA